Detalhe da pesquisa
1.
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts.
Haematologica
; 102(4): 773-784, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28057743
2.
The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells.
Haematologica
; 101(3): e107-10, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26659917
3.
Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules.
Exp Hematol
; 41(4): 387-97.e1, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23178378